{"id":849860,"date":"2026-08-07T21:52:15","date_gmt":"2026-08-07T21:52:15","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/849860\/"},"modified":"2026-08-07T21:52:15","modified_gmt":"2026-08-07T21:52:15","slug":"why-nova-scotia-was-chosen-to-test-a-new-ebola-vaccine","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/849860\/","title":{"rendered":"Why Nova Scotia was chosen to test a new Ebola vaccine"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.cbc.ca\/a\/assets\/texttospeech.svg\" alt=\"Text to Speech Icon\" width=\"44\" height=\"44\"\/><\/p>\n<p>Listen to this article<\/p>\n<p>Estimated 3 minutes<\/p>\n<p>The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results.<\/p>\n<p>The first human trial of a new Ebola vaccine is underway at two sites in Nova Scotia as well as in Toronto.<\/p>\n<p>The vaccine, created by Moderna, targets Bundibugyo Ebola virus, a deadly strain that has been <a href=\"https:\/\/www.cbc.ca\/news\/health\/ebola-vaccine-trial-health-canada-moderna-9.7295616\" target=\"_blank\" rel=\"nofollow noopener\">surging in the Democratic Republic of Congo<\/a>, causing more than 1,700 known deaths and 3,800 infections during the recent outbreak.<\/p>\n<p>The first participant received the vaccine in Truro, N.S., on Monday. A total of 80 volunteers will receive the vaccine across the three sites, including Truro, Halifax and Toronto.<\/p>\n<p>Hamilton Bennett, Moderna&#8217;s executive director of health security, research and development and partnerships, told Radio-Canada that the three sites were chosen for the Phase 1 study because of the company&#8217;s previous positive experiences working with partners there.<\/p>\n<p>&#8220;Nova Scotia has incredibly deep vaccine experience that Moderna has seen firsthand,&#8221; Bennett said.  <\/p>\n<p>&#8220;When you&#8217;re trying to move at the pace that we&#8217;re trying to move with this Ebola outbreak, understanding who your partner is on the other side of the phone is really important.<\/p>\n<p>&#8220;Trusting that they&#8217;re going to be able to work with you to deliver on time and with quality is really important. And we&#8217;ve had that experience with these sites before and we were more than keen to work with them again on this trial.&#8221;<\/p>\n<p>&#8216;People are very altruistic&#8217;<\/p>\n<p>Scott Halpern, the principal investigator for the clinical trial in Halifax and a professor of pediatrics and microbiology and immunology at Dalhousie University, said &#8220;people are very altruistic&#8221; and willing to participate in vaccine trials in Canada.<\/p>\n<p>&#8220;When they see that a vaccine is being developed for an emergency outbreak like this, even though it&#8217;s not a risk to them and likely never will be, people are still interested in volunteering in order to contribute to developing vaccines that are going to save lives elsewhere,&#8221; Halpern said.<\/p>\n<p>The Phase 1 vaccine trial is primarily intended to assess the safety of the vaccine, such as whether it causes pain at the injection site, fevers, fatigue or other side effects.<\/p>\n<p>It will also assess the participants&#8217; immune response to the vaccine, including whether they produce a strong antibody response.<\/p>\n<p>Participants will be intensively monitored over the first week, with ongoing monitoring taking place over the next year to track any long-term side effects.<\/p>\n<p>Halpern said participants will be recruited through social media, a website and a database of people who have been involved in trials in the past. He said they usually receive a small amount of money \u2014 typically between $50 and $100 \u2014 for participating.<\/p>\n<p>The next phases of clinical development will occur in East Africa in or near the outbreak zone.<\/p>\n<p>MORE TOP STORIES<\/p>\n","protected":false},"excerpt":{"rendered":"Listen to this article Estimated 3 minutes The audio version of this article is generated by AI-based technology.&hellip;\n","protected":false},"author":2,"featured_media":849861,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[49,48,84],"class_list":["post-849860","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-ca","tag-canada","tag-health"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/849860","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=849860"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/849860\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/849861"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=849860"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=849860"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=849860"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}